Aniracetam (Ro 13-5057) in the treatment of senile dementia of Alzheimer type (SDAT): results of a placebo controlled multicentre clinical study.
about
The use of medications for cognitive enhancement.Fetal alcohol spectrum disorders and abnormal neuronal plasticity.Efficacy of acetylcholinesterase inhibitors versus nootropics in Alzheimer's disease: a retrospective, longitudinal study.Multiple-dose plasma pharmacokinetic and safety study of LY450108 and LY451395 (AMPA receptor potentiators) and their concentration in cerebrospinal fluid in healthy human subjects.Clinical Efficacy of Aniracetam, Either as Monotherapy or Combined with Cholinesterase Inhibitors, in Patients with Cognitive Impairment: A Comparative Open Study*
P2860
Aniracetam (Ro 13-5057) in the treatment of senile dementia of Alzheimer type (SDAT): results of a placebo controlled multicentre clinical study.
description
1991 nî lūn-bûn
@nan
1991 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Aniracetam (Ro 13-5057) in the ...... ed multicentre clinical study.
@ast
Aniracetam (Ro 13-5057) in the ...... ed multicentre clinical study.
@en
Aniracetam
@nl
type
label
Aniracetam (Ro 13-5057) in the ...... ed multicentre clinical study.
@ast
Aniracetam (Ro 13-5057) in the ...... ed multicentre clinical study.
@en
Aniracetam
@nl
prefLabel
Aniracetam (Ro 13-5057) in the ...... ed multicentre clinical study.
@ast
Aniracetam (Ro 13-5057) in the ...... ed multicentre clinical study.
@en
Aniracetam
@nl
P2093
P921
P1476
Aniracetam (Ro 13-5057) in the ...... ed multicentre clinical study.
@en
P2093
Parnetti L
Villardita C
P304
P356
10.1016/0924-977X(91)90004-E
P407
P577
1991-12-01T00:00:00Z